| Title : Preclinical evaluation of homodimeric FAPI target modules for UniCAR-mediated targeting of FAP-expressing tumor and stromal cells - Boutier_2026_Oncoimmunology_15_2717836 |
| Author(s) : Boutier H , Mattiussi S , Loureiro LR , Berndt N , Stammberger A , Jones-Cifuentes N , Hoffmann L , Verhulst E , Schmitz M , De Meester I , Battisti UM , Arndt C , Feldmann A , Roesch F , Herth MM , Bachmann M |
| Ref : Oncoimmunology , 15 :2717836 , 2026 |
| Abstract : |
| PubMedSearch : Boutier_2026_Oncoimmunology_15_2717836 |
| PubMedID: 42627862 |
| Title : FAP-Inhibitor Homodimers with Engineered Linker-Spacer Units: Toward Optimized Radiopharmaceuticals - Kumar_2026_ACS.Omega_11_49001 |
| Author(s) : Kumar N , Martin M , Bilinska A , Menendez E , De Meester I , Roesch F , Rominger A , Gourni E |
| Ref : ACS Omega , 11 :49001 , 2026 |
| Abstract : |
| PubMedSearch : Kumar_2026_ACS.Omega_11_49001 |
| PubMedID: 42662658 |
| Title : Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure-Function Relationships, and Preclinical Performance - Wu_2026_Molecules_31_2124 |
| Author(s) : Wu Z , Gourni E , Ballal S , Van der Veken P , Roesch F |
| Ref : Molecules , 31 : , 2026 |
| Abstract : |
| PubMedSearch : Wu_2026_Molecules_31_2124 |
| PubMedID: 42357520 |
| Title : Efficacy and Safety of [(177)Lu]Lu-DOTAGA.Glu.(FAPi)(2) Therapy in Patients with Sarcoma - Ballal_2025_J.Nucl.Med_66_1612 |
| Author(s) : Ballal S , Sakir M , Chandekar KR , Rastogi S , Yadav MP , Roesch F , Tripathi M , Martin M , Bal C |
| Ref : J Nucl Med , 66 :1612 , 2025 |
| Abstract : |
| PubMedSearch : Ballal_2025_J.Nucl.Med_66_1612 |
| PubMedID: 40841150 |
| Title : [(68)Ga]Ga-DOTAGA-Glu(FAPi)(2) Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging - Mortensen_2024_Diagnostics.(Basel)_14_ |
| Author(s) : Mortensen JVK , Mattiussi S , Hvass L , Lund EG , Shalgunov V , Roesch F , Battisti UM , Herth MM , Kjaer A |
| Ref : Diagnostics (Basel) , 14 : , 2024 |
| Abstract : |
| PubMedSearch : Mortensen_2024_Diagnostics.(Basel)_14_ |
| PubMedID: 39335703 |
| Title : [(177)Lu]Lu-DOTAGA.Glu.(FAPi)(2) Radionuclide Therapy: a New Treatment Option for Patients with Glioblastoma Multiforme - Ballal_2024_Nucl.Med.Mol.Imaging_58_32 |
| Author(s) : Ballal S , Yadav MP , Raju S , Roesch F , Martin M , Tripathi M , Bal C |
| Ref : Nucl Med Mol Imaging , 58 :32 , 2024 |
| Abstract : |
| PubMedSearch : Ballal_2024_Nucl.Med.Mol.Imaging_58_32 |
| PubMedID: 38261876 |
| Title : Therapeutic potential of [(177)Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment - Yadav_2024_Eur.J.Nucl.Med.Mol.Imaging_51_805 |
| Author(s) : Yadav MP , Ballal S , Martin M , Roesch F , Satapathy S , Moon ES , Tripathi M , Gogia A , Bal C |
| Ref : Eur J Nucl Med Mol Imaging , 51 :805 , 2024 |
| Abstract : |
| PubMedSearch : Yadav_2024_Eur.J.Nucl.Med.Mol.Imaging_51_805 |
| PubMedID: 37932560 |
| Title : Head-to-Head Comparison between [(68)Ga]Ga-DOTA.SA.FAPi and [(18)F]F-FDG PET\/CT Imaging in Patients with Breast Cancer - Ballal_2023_Pharmaceuticals.(Basel)_16_ |
| Author(s) : Ballal S , Yadav MP , Roesch F , Wakade N , Raju S , Sheokand P , Mishra P , Moon ES , Tripathi M , Martin M , Bal C |
| Ref : Pharmaceuticals (Basel) , 16 : , 2023 |
| Abstract : |
| PubMedSearch : Ballal_2023_Pharmaceuticals.(Basel)_16_ |
| PubMedID: 37111277 |
| Title : Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics - Martin_2023_Cancers.(Basel)_15_ |
| Author(s) : Martin M , Ballal S , Yadav MP , Bal C , Van Rymenant Y , De Loose J , Verhulst E , De Meester I , Van der Veken P , Roesch F |
| Ref : Cancers (Basel) , 15 : , 2023 |
| Abstract : |
| PubMedSearch : Martin_2023_Cancers.(Basel)_15_ |
| PubMedID: 36980775 |
| Title : Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time - Moon_2021_Am.J.Nucl.Med.Mol.Imaging_11_476 |
| Author(s) : Moon ES , Ballal S , Yadav MP , Bal C , Van Rymenant Y , Stephan S , Bracke A , Van der Veken P , De Meester I , Roesch F |
| Ref : Am J Nucl Med Mol Imaging , 11 :476 , 2021 |
| Abstract : |
| PubMedSearch : Moon_2021_Am.J.Nucl.Med.Mol.Imaging_11_476 |
| PubMedID: 35003886 |
| Title : Biodistribution, pharmacokinetics, dosimetry of [(68)Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [(18)F]F-FDG PET\/CT in patients with various cancers - Ballal_2021_Eur.J.Nucl.Med.Mol.Imaging_48_1915 |
| Author(s) : Ballal S , Yadav MP , Moon ES , Kramer VS , Roesch F , Kumari S , Tripathi M , ArunRaj ST , Sarswat S , Bal C |
| Ref : Eur J Nucl Med Mol Imaging , 48 :1915 , 2021 |
| Abstract : |
| PubMedSearch : Ballal_2021_Eur.J.Nucl.Med.Mol.Imaging_48_1915 |
| PubMedID: 33244617 |
| Title : Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET\/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours - Kreppel_2021_Nuklearmedizin_60_344 |
| Author(s) : Kreppel B , Gonzalez-Carmona MA , Feldmann G , Kuppers J , Moon ES , Marinova M , Bundschuh RA , Kristiansen G , Essler M , Roesch F , Gaertner FC |
| Ref : Nuklearmedizin , 60 :344 , 2021 |
| Abstract : |
| PubMedSearch : Kreppel_2021_Nuklearmedizin_60_344 |
| PubMedID: 34256394 |